Evidence map›Paper›PMID 26402697›Full record

ArticleNutrients2015

Duality of n-3 Polyunsaturated Fatty Acids on Mcp-1 Expression in Vascular Smooth Muscle: A Potential Role of 4-Hydroxy Hexenal.

Kohji Nagayama, Katsutaro Morino, Osamu Sekine, Fumiyuki Nakagawa, Atsushi Ishikado, Hirotaka Iwasaki, Takashi Okada, Masashi Tawa, Daisuke Sato, Takeshi Imamura and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Kohji NagayamaDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. nagayama@belle.shiga-med.ac.jp.
Katsutaro MorinoDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. morino@belle.shiga-med.ac.jp.
Osamu SekineDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. sekine@belle.shiga-med.ac.jp.
Fumiyuki NakagawaDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. f.nakagawa@jclbio.com.
Atsushi IshikadoDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. atsushi.ishikado@jp.sunstar.com.
Hirotaka IwasakiDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. hiwasaki@belle.shiga-med.ac.jp.
Takashi OkadaDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. tokada@belle.shiga-med.ac.jp.
Masashi TawaDepartment of Pharmacology, Shiga University of Medical Science, Shiga 520-2192, Japan. tawa@belle.shiga-med.ac.jp.
Daisuke SatoDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. dkst0310@belle.shiga-med.ac.jp.
Takeshi ImamuraDepartment of Pharmacology, Shiga University of Medical Science, Shiga 520-2192, Japan. timamura@belle.shiga-med.ac.jp.
Yoshihiko NishioDepartment of Diabetes and Endocrine Medicine, Kagoshima University, Kagoshima 890-8580, Japan. ynishio@m3.kufm.kagoshima-u.ac.jp.
Satoshi UgiDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. sugi@belle.shiga-med.ac.jp.
Atsunori KashiwagiKusatsu General Hospital, 1660, Yabase-cho, Kusatsu, Shiga 525-8585, Japan. kashiwagi@kusatsu-gh.or.jp.
Tomio OkamuraDepartment of Pharmacology, Shiga University of Medical Science, Shiga 520-2192, Japan. okamura@belle.shiga-med.ac.jp.
Hiroshi MaegawaDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan. maegawa@belle.shiga-med.ac.jp.
Shiga University of Medical Science · JPJoslin Diabetes Center · USKagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) have protective effects against atherosclerosis. Monocyte chemotactic protein (MCP)-1 is a major inflammatory mediator in the progression of atherosclerosis. However, little is known about the regulation of MCP-1 by DHA and EPA in vessels and vascular smooth muscle cells (VSMCs). In this study, we compared the effect of DHA and EPA on the expression of Mcp-1 in rat arterial strips and rat VSMCs. DHA, but not EPA, suppressed Mcp-1 expression in arterial strips. Furthermore, DHA generated 4-hydroxy hexenal (4-HHE), an end product of n-3 polyunsaturated fatty acids (PUFAs), in arterial strips as measured by liquid chromatography-tandem mass spectrometry. In addition, 4-HHE treatment suppressed Mcp-1 expression in arterial strips, suggesting 4-HHE derived from DHA may be involved in the mechanism of this phenomenon. In contrast, Mcp-1 expression was stimulated by DHA, EPA and 4-HHE through p38 kinase and the Keap1-Nuclear factor erythroid-derived 2-like 2 (Nrf2) pathway in VSMCs. In conclusion, there is a dual effect of n-3 PUFAs on the regulation of Mcp-1 expression. Further study is necessary to elucidate the pathological role of this phenomenon.

Indexed as

AldehydesAnimalsAorta, ThoracicCells, CulturedChemokine CCL2Chromatography, LiquidDocosahexaenoic AcidsDose-Response Relationship, DrugDown-RegulationEicosapentaenoic AcidIn Vitro TechniquesMaleMuscle, Smooth, VascularMyocytes, Smooth MuscleNF-E2-Related Factor 2p38 Mitogen-Activated Protein Kinases4-hydroxy-2-hexenalAldehydesCcl2 protein, ratChemokine CCL2Docosahexaenoic AcidsEicosapentaenoic AcidNfe2l2 protein, ratNF-E2-Related Factor 2p38 Mitogen-Activated Protein Kinases4-hydroxy hexenaldocosahexaenoic acideicosapentaenoic acidmonocyte chemotactic protein 1

Identifiers

PMID26402697
PMCPMC4586576
OpenAlexW2149352307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.